SEC Form 4 · accession 0000932440-17-000002
EAGLE PHARMACEUTICALS, INC. · EGRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Jay Moorin
10% Owner
Alain Schreiber
10% Owner
ProQuest Investments IV, L.P.
10% Owner
ProQuest Associates IV LLC
10% Owner
ProQuest Financial LLC
10% Owner
Period of report
Jan 4, 2017
Accepted (ET)
Jan 6, 2017 · 4:39 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000827871
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock $0.001 par valueF3,F1 | Jan 4, 2017 | S | 65,114 | $85.16 | D | 3,879,287 | I | By ProQuest Investments IV, L.P. |
| Common Stock $0.001 par valueF2 | holding | — | — | — | 7,677 | I | By ProQuest Financial LLC | |
| Common Stock $0.001 par value | holding | — | — | — | 26,174 | I | By Jay Moorin through IRA |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares are held by ProQuest Investments IV, L.P. ("Investments IV"), which ProQuest Financial LLC ("ProQuest Financial") manages. Jay Moorin and Alain Schreiber are managing members of ProQuest Financial and each of them disclaims beneficial ownership of such securities except to the extent of his pecuniary interest in such securities.
- F2Jay Moorin and Alain Schreiber are managing members of ProQuest Financial and each of them disclaims beneficial ownership of such securities except to the extent of his pecuniary interest in such securities.
- F3Constitutes the weighted average purchase price for multiple transactions reported on this line having prices per share ranging from $85.00 to $85.92. The Reporting Persons will provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding each separate transaction.